A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

The OHSU researchers call their test “PAC-MANN,” which stands for “protease activity-based assay using a magnetic nanosensor.

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

Cedars-Sinai investigators are developing a tool using artificial intelligence to help predict pancreatic cancer in Black ...

OHSU's PAC-MANN test offers a breakthrough in pancreatic cancer detection, using a small blood sample to monitor protease ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.